PT-141 (Peptide) – Product Details

• This peptide is offered as a 10mg lyophilized powder.

PT 141 was initially developed as a potential treatment for postmenopausal women experiencing reduced sexual desire. Clinical research has shown that it can potentially increase sexual desire in this group, as well as improve erectile response/sexual desire in healthy males.

PT 141 has also demonstrated the potential ability to increase erectile response in Viagra-responsive erectile dysfunction (ED) patients. In clinical studies involving males, PT-141 was well-tolerated by the subjects and didn’t produce any significant changes in vital signs.

Behemoth Labz sells PT 141 for laboratory research use only.

PT-141 Research Peptide

• CAS Number is stated as 189691-06-3
• Molar Mass is 182g·mol−1
• It has a Chemical Formula of C50H68N14O10
• IUPAC Name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid;acetic acid
• Also known by Synonyms as Bremelanotide Acetate

What is PT 141?

PT 141, also known as Bremelanotide, is a melanocortin-based peptide. It is a synthetic peptide analog of alpha-melanocyte-stimulating hormone. Alpha-MSH is a naturally occurring hormone well known for its potential anti-inflammatory and antipyretic (fever-reducing) effects. [R]

PT 141 was initially developed as a potential treatment for postmenopausal women experiencing reduced sexual desire for no apparent reason. Clinical research indicates that it may be a potential treatment for female sexual dysfunctions, such as hypoactive sexual desire disorder. [R]

The FDA has approved PT 141 for treating hypoactive sexual desire disorder (HSDD) in pre-menopausal women. HSDD is characterized by decreased sexual desire that causes distress and is not due to any medical or psychiatric condition, drugs, or relationship issues. [R]

PT 141 has also demonstrated the potential ability to increase sexual desire in males. In clinical studies, this peptide has shown the potential to enhance erectile activity in healthy males as well as Viagra-responsive ED patients. Behemoth Labz sells PT 141 for research use and not for human consumption. [R][R]

How Does PT 141 Work?

PT 141 may bind to specific melanocortin receptors (MCRs) in the central nervous system. Melanocortin receptors are a family of five proteins, ranging from MC1R – MC5R. They regulate inflammation, sexual function, pigmentation, and energy homeostasis in your body. [R]

PT 141 potentially displays a high binding affinity for MC1R, MC3R, and MC4R, with a preference for MC4R. This is significant. MC4R is involved with energy homeostasis, sexual activity, nociception, inflammation, and neuroprotection. In mice, MC4R’s inhibition led to obesity. [R][R]

PT 141 Research

Various clinical studies have been conducted to explore the potential effects of PT141. These trials have shown that PT 141 may improve sexual desire or libido in pre-menopausal women with sexual arousal disorder, as well as in healthy males and in erectile dysfunction patients.

All the information given below is for educational purposes only. Behemoth Labz only sells PT141 for laboratory research purposes and not for human use.

PT 141 and Sexual Desire Disorders

In a double-blind, placebo-controlled trial, 18 pre-menopausal women with a primary diagnosis of sexual desire disorder (sexual arousal dysfunction) were randomly assigned to receive PT 141 or placebo. The study was completed in two in-clinic treatment sessions.

More women reported moderate or high sexual desire following PT 141 treatment compared to placebo. Among women who attempted sexual intercourse within 24 hours, significantly more were satisfied with their level of sexual desire following PT 141 vs. placebo. [R]

Another trial was conducted to determine the safety and efficacy of long-term PT141 treatment on pre-menopausal women with low sexual desire. It confirmed the long-term safety of PT141 in women with low sexual desire who received this drug for up to 76 weeks. [R]

PT 141 and Erectile Dysfunction

In one clinical study, intranasal administration of PT 141 potentially produced a statistically significant erectile response in healthy males and in Viagra-responsive ED patients. At doses greater than 7 mg, the onset of the first erection occurred in approximately 30 minutes. [R]

Another study explored the effects of PT 141 in ED patients who reported an inadequate response to Viagra. ED patients were treated with a placebo, 4 or 6 mg PT 141. Results show that PT 141 was potentially able to induce a significant erectile response at doses greater than 1.0 mg.

Thus, this sexual medicine could be a potential alternative treatment for ED. [R]

PT 141 and Body Weight

Data from two phase 1 randomized trials indicate that PT141 may potentially stimulate weight loss by reducing caloric intake in obese women. In Study A, 27 of 30 (90%) PT141 subjects completed the trial and exhibited a potentially significantly greater reduction in body weight compared to placebo. [R]

In Study B, a potentially significantly greater reduction of mean body weight occurred in twice-daily PT 141 subjects versus placebo. Total caloric intake reduction was higher in PT 141 groups vs. placebo. These results indicate that agonist activity at MC4R may potentially cause weight loss in obese women.

PT 141 and Sexually Related Distress

A double-blind, placebo-controlled trial was conducted to investigate the potential effects of PT 141 on sexually related distress in pre-menopausal women. Three hundred and twenty-seven at-home users were randomly assigned PT 141 or placebo. [R]

Results from the study show that subcutaneous PT 141 administration had the potential to reduce sexual-related distress, including distress regarding feeling bothered by low sexual desire. Pre-menopausal women with HSDD, FSAD, or both were enlisted for this study.

Frequently Asked Questions

Is PT 141 Legal?

The US Food and Drug Administration (FDA) has approved PT 141 as a treatment for hypoactive sexual desire disorder in pre-menopausal women. Behemoth Labz sells PT141 for laboratory research purposes only. Speak to your doctor to learn more about this compound.

What are the side effects of PT141?

According to clinical trials, the most common potential side effects of PT 141 are nausea, flushing, headache, and vomiting. As much as 40% of patients who took part in the clinical trials experienced nausea.

Where to Buy PT 141 for Sale?

BehemothLabz is the best place to buy PT 141 online.

We have been around since 2014, supplying the highest-quality research compounds money can buy. All of our products come with a 100% satisfaction guarantee, free shipping, and a money-back guarantee. Plus, they are all 3^rd-party tested to ensure safety and purity.

PT 141 Summary

PT 141 is a synthetic peptide analog of alpha-MSH, a peptide hormone naturally produced in the body.

In various clinical trials, PT 141 has demonstrated the potential ability to treat female sexual dysfunction and stimulate sexual behavior in females with HSDD. It has also been found to potentially stimulate penile erection in men with psychogenic erectile dysfunction.

BehemothLabz Disclaimer

Please make sure you go through the Terms and Conditions, and please familiarize yourself with it as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product. Customer satisfaction is our number one priority!

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Variation	10mg

COA